 |
N-acetyl-procainamide |
|---|---|
| Trade Name | |
| Orphan Indication | Prevention of life-threatening ventricular arrhythmias in patients with documented procainamide-induced lupus |
| USA Market Approval | USA |
| USA Designation Date | 1996-12-10 00:00:00 |
| Sponsor | NAPA of the Bahamas;3560 Pennsylvania Avenue, Suite 7;Dubuque, Iowa, 52002 |
